| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Oxycodone/naloxone |
| Brand | Targin® |
| Indication | For severe pain, which can be adequately managed only with opioid analgesics. |
| Assessment Process | |
| Full pharmacoeconomic assessment commissioned by HSE | 05/05/2010 |
| NCPE assessment completed | 12/07/2010 |
13/07/2010
We do not recommend reimbursement of oxycodone/naloxone (Targin®) under the Community Drugs Schemes at the proposed price.
19/10/2010
Following a price revision oxycodone/naloxone (Targin®) is now reimbursed under the Community Drugs Schemes.